Top 5 Oral Dosage Forms By Expenditure
Source: ISR Reports
In Q2 2021, ISR asked 100 outsourcers of oral dose manufacturing to allocate the proportion of their company’s outsourced expenditure by dosage form. The data show that traditional tablets currently account for the largest proportion of spend, followed by controlled release tablets and immediate release tablets. However, respondents predict some of the current spend on tablets will shift to capsules five years from now. To learn more, follow the link to the Oral Dosage Forms Market Outlook report preview.
access the Infographic!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
ISR Reports
This website uses cookies to ensure you get the best experience on our website. Learn more